- Home
- AMBC vs PHAR Comparison
AMBC vs PHAR Comparison
Compare AMBC & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMBC
- PHAR
- Stock Information
- Founded
- AMBC 1971
- PHAR 1988
- Country
- AMBC United States
- PHAR Netherlands
- Employees
- AMBC N/A
- PHAR N/A
- Industry
- AMBC Property-Casualty Insurers
- PHAR Biotechnology: Pharmaceutical Preparations
- Sector
- AMBC Finance
- PHAR Health Care
- Exchange
- AMBC Nasdaq
- PHAR Nasdaq
- Market Cap
- AMBC 411.3M
- PHAR 731.1M
- IPO Year
- AMBC 1991
- PHAR N/A
- Fundamental
- Price
- AMBC $7.27
- PHAR $10.42
- Analyst Decision
- AMBC Strong Buy
- PHAR Strong Buy
- Analyst Count
- AMBC 2
- PHAR 3
- Target Price
- AMBC $12.50
- PHAR $30.00
- AVG Volume (30 Days)
- AMBC 912.6K
- PHAR 3.5K
- Earning Date
- AMBC 08-04-2025
- PHAR 07-31-2025
- Dividend Yield
- AMBC N/A
- PHAR N/A
- EPS Growth
- AMBC N/A
- PHAR N/A
- EPS
- AMBC N/A
- PHAR N/A
- Revenue
- AMBC $253,912,000.00
- PHAR $320,708,000.00
- Revenue This Year
- AMBC N/A
- PHAR $13.31
- Revenue Next Year
- AMBC $17.41
- PHAR $7.68
- P/E Ratio
- AMBC N/A
- PHAR N/A
- Revenue Growth
- AMBC 125.08
- PHAR 24.13
- 52 Week Low
- AMBC $5.99
- PHAR $6.65
- 52 Week High
- AMBC $13.64
- PHAR $12.61
- Technical
- Relative Strength Index (RSI)
- AMBC 49.50
- PHAR 48.06
- Support Level
- AMBC $6.87
- PHAR $9.99
- Resistance Level
- AMBC $8.07
- PHAR $10.49
- Average True Range (ATR)
- AMBC 0.29
- PHAR 0.33
- MACD
- AMBC 0.03
- PHAR -0.11
- Stochastic Oscillator
- AMBC 28.69
- PHAR 29.19
About AMBC Ambac Financial Group Inc.
Ambac Financial Group Inc is a financial services holding company. It operates in two principal businesses segments: Insurance Distribution and Specialty Property & Casualty Insurance. Insurance Distribution segment includes Managing General Agents, Underwriters and other appointed and delegated underwriting businesses (collectively MGAs or MGA/Us), an insurance broker, and other distribution and underwriting businesses. Specialty Property & Casualty Insurance includes five carriers (collectively, Everspan). Key revenue is generated from Insurance Distribution.
About PHAR Pharming Group N.V.
Pharming Group is a biopharmaceutical company focused in transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company is actively developing and commercializing a diverse portfolio of innovative treatments, including both biologics and small molecule therapies. Its commercial products are RUCONEST, approved for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema, or HAE; and Joenja (leniolisib), a small-molecule kinase inhibitor, developed for the treatment of activated phosphoinositide 3-kinase delta syndrome.